RARE-29. PROGRAMMED DEATH LIGAND 1 EXPRESSION AND TUMOR INFILTRATING LYMPHOCYTES IN TUMORS ASSOCIATED WITH NEUROFIBROMATOSIS TYPE 1 AND 2

BACKGROUND: Immune checkpoint inhibitors targeting programmed cell death 1 (PD-1) or its ligand (PD-L1) have been shown to be effective in treating patients with a variety of cancers. Positive associations between clinical response rates and PD-L1 expression on tumor and immune cells, as well as the...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Wang, Shiyang, Liechty, Benjamin, Patel, Seema, Weber, Jeffrey, Hollman, Travis, Snuderl, Matija, Karajannis, Matthias
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2017
Matèries:
Abstracts
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692798/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.873
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars